Kozak & Associates, Inc. Novartis Ag Transaction History
Kozak & Associates, Inc.
- $482 Million
- Q2 2025
A detailed history of Kozak & Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Kozak & Associates, Inc. holds 1,000 shares of NVS stock, worth $119,310. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$119,310% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.41 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$807 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...